Zoetis | ZTS - Assets


Zoetis reported $15.09B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
AbbVie USD 147.68B 12.57B Sep/2026
Align Technology USD 6.52B 103.03M Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Dentsply International USD 5.19B 14M Sep/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Henry Schein USD 11.51B 129M Sep/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Illumina USD 6.81B 162M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Laboratory Of America USD 18.92B 392.3M Sep/2026
Merck USD 132.77B 2.97B Sep/2026
Neogen USD 3.3B 42.8M Jun/2026
Pacira USD 34.68B 33.44B Sep/2026
Perrigo USD 7.48B 124.6M Sep/2026
Pfizer USD 204.54B 3.41B Sep/2026
Phibro Animal Health USD 1.51B 13.48M Sep/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Zoetis USD 15.09B 11M Sep/2026